Redel Trial: Reduced Elective Nodal Dose For Anal Cancer Toxicity Mitigation
Posted Date: Apr 25, 2024
- Investigator: Jordan Kharofa
- Specialties: Cancer, Radiation Oncology
- Type of Study: Drug
To determine the efficacy of reduced elective nodal radiation in anal cancer patients undergoing chemoradiation in reducing toxicity compared to standard nodal irradiation.
Criteria:
Null
Keywords:
Anal Cancer, Radiation
For More Information:
Andrea Ordonez
NULL
cancer@uchealth.com